Clinical Trial Update: Combination Immunotherapy in Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of combination immunotherapy in colorectal cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Colorectal Neoplasms | Phase 2 | Status: SUSPENDED